• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dev Ctries . Prognostic factors for COVID-19 patients

tetano

Editor, Senior Moderator
J Infect Dev Ctries


. 2022 Mar 31;16(3):409-417.
doi: 10.3855/jidc.15845.
Prognostic factors for COVID-19 patients


Uğur Önal[SUP] 1 [/SUP], Özge Aydın Güçlü[SUP] 2 [/SUP], Halis Akalın[SUP] 3 [/SUP], Nilüfer Aylin Acet Öztürk[SUP] 2 [/SUP], Cihan Semet[SUP] 3 [/SUP], Ezgi Demirdöğen[SUP] 2 [/SUP], Aslı Görek Dilektaşlı[SUP] 2 [/SUP], İmran Sağlık[SUP] 4 [/SUP], Esra Kazak[SUP] 3 [/SUP], Güven Özkaya[SUP] 5 [/SUP], Funda Coşkun[SUP] 2 [/SUP], Dane Ediger[SUP] 2 [/SUP], Yasemin Heper[SUP] 3 [/SUP], Ahmet Ursavaş[SUP] 2 [/SUP], Emel Yılmaz[SUP] 3 [/SUP], Esra Uzaslan[SUP] 2 [/SUP], Mehmet Karadağ[SUP] 2 [/SUP]



Affiliations

Abstract

Introduction: Determining prognostic factors in patients with coronavirus disease (COVID-19) can have great impact on treatment planning and follow-up strategies. Herein, we aimed to evaluate prognostic factors and clinical scores for confirmed COVID-19 patients in a tertiary-care hospital in the Bursa region of Turkey.
Methodology: Patients who had been diagnosed with COVID-19 microbiologically and/or radiologically between March and October 2020 in a tertiary-care university hospital were enrolled retrospectively. Adult patients (≥ 18 years) with a clinical spectrum of moderate, severe, or critical illness were included. The dependent variable was 30-day mortality and logistic regression analysis was used to evaluate any variables with a significant p value (< 0.05) in univariate analysis.
Results: A total of 257 patients were included in the study. The mortality rate (30-day) was 14.4%. In logistic regression analysis, higher scores on sequential organ failure assessment (SOFA) (p < 0.001, odds ratio (OR) = 1.86, 95% CI = 1.42-2.45) and CURB-65 pneumonia severity criteria (p = 0.001, OR = 2.60, 95% CI = 1.47-4.57) were found to be significant in predicting mortality at admission. In deceased patients, there were also significant differences between the baseline, day-3, day-7, and day-14 results of D-dimer (p = 0.01), ferritin (p = 0.042), leukocyte (p = 0.019), and neutrophil (p = 0.007) counts.
Conclusions: In our study of COVID-19 patients, we found that high SOFA and CURB-65 scores on admission were associated with increased mortality. In addition, D-dimer, ferritin, leukocyte and neutrophil counts significantly increased after admission in patients who died.

Keywords: COVID-19; CURB-65; SOFA; prognostic factors.
 
Back
Top Bottom